National Institute of Allergy and Infectious Diseases (NIAID)

🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers

An analysis of HIV Prevention Trials Network (HPTN) studies of long-acting injectable cabotegravir for #HIV pre-exposure prophylaxis (CAB-LA PrEP) showed that some people who acquired HIV while taking CAB-LA had lower HIV DNA levels than those on tenofovir-based PrEP. Learn more: https://lnkd.in/enGvBGEB Johns Hopkins Pathology FHI 360 Centers for Disease Control and Prevention Wits RHI IAVI ViiV Healthcare Gilead Sciences UNC Department of Medicine UCLA Health

Tamara Haque, Ph.D., is a #postdoctoral fellow in the Food Allergy Research Unit of the Laboratory of Allergic Diseases who received this year's Postbac Distinguished Mentor Award. This honor recognizes individuals who exemplify excellence in mentorship, and a commitment to supporting #postbaccalaureate trainees. Read Tamara's reflections on #mentorship and how postdoctoral mentors can help their postbaccalaureate mentees get the most from their training experience: https://go.nih.gov/rzGfY39 #NIAIDTraining

Licensing Opportunity: Monoclonal Antibodies That Bind to the Underside of Influenza Viral Neuraminidase - A Potential Vaccine Target Circulating seasonal influenza viruses cause substantial morbidity and mortality and pose global public health and economic challenges. Current influenza vaccines mainly induce antibodies against the surface glycoprotein hemagglutinin (HA). However, these antibodies confer little cross protection between strains or subtypes. Researchers at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases have now identified human monoclonal antibodies that bind to the less abundant yet critical viral surface glycoprotein neuraminidase (NA). These antibodies inhibit a wide range of H3N2, swine-origin variant H3N2, and H2N2 viruses and have already demonstrated protective effects in animal models. To learn more about this collaboration opportunity, visit https://bit.ly/4hwUkcC or contact Haiqing Li at lihai@mail.nih.gov and reference E-177-2022. #Influenza #Flu #NIAID #Vaccine #Virus #NIAIDTechTransfer

Learn about the Institute’s #mpox research agenda in this video with #NIAIDDirector Dr. Jeanne Marrazzo: https://lnkd.in/e3rxhw2r

A #NIAID-sponsored clinical trial has launched to examine the safety and acceptability of a novel rectal HIV #microbicide for #HIV prevention. #NIH remains committed to developing safe and effective HIV prevention methods that people need, want, and are able to use. Learn more: https://go.nih.gov/W3S36dn The National Institutes of Health

📢 NIAID is attending the SACNAS #NDiSTEM2024 conference October 31 – November 2 to promote #DiversityinSTEM! Stop by booths 708 and 710 to explore career and training opportunities in allergic, immunologic, and infectious diseases. #NIAIDTraining #NIAIDCareers #STEMCareers #Research

#HappyHalloween 🎃 Foods that don’t contain allergens can be made in the same place as foods that do. Read labels carefully and stay safe this Halloween! Learn more about #FoodAllergies at https://go.nih.gov/6ulZP3b

Learn about the STOMP #mpox therapeutics trial in the United States and other countries affected by Clade II virus in this video with Dr. Cyrus Javan of the #NIAID Division of AIDS: https://lnkd.in/egxMxnJt

📢 We're hiring! #NIAID is seeking an exceptional leader to serve as chief of the Virology Branch (VB) within the Division of Microbiology and Infectious Diseases (DMID). The chief of VB directs a complex program that promotes basic, translational, and clinical research and advances product development for prominent viral infectious diseases other than HIV. Reporting to the DMID director, the chief oversees efforts to understand the biology and pathogenesis of 200+ viruses across 20+ viral families, including pandemic threats, and shape scientific priorities aligned with NIH, HHS, and broader U.S. and global health goals. Applications are due 11/26. Learn more and #ApplyNow at https://go.nih.gov/9V88FCa #NowHiring #NIAIDCareers #JobOpening #NIAIDResearch